Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study.
Brenda DorcelyEliud SifonteCollin PoppAnjana DivakaranKarin KatzSarah MuslehRam JagannathanMargaret CurranMary Ann SevickJosé O AlemanIra J GoldbergMichael BergmanPublished in: Endocrine (2022)